Recurrent diabetic ketoacidosis.


Journal

Archives of endocrinology and metabolism
ISSN: 2359-4292
Titre abrégé: Arch Endocrinol Metab
Pays: Brazil
ID NLM: 101652058

Informations de publication

Date de publication:
2019
Historique:
received: 18 07 2018
accepted: 17 03 2019
pubmed: 1 8 2019
medline: 2 11 2019
entrez: 1 8 2019
Statut: epublish

Résumé

The purpose of this study is to examine risk factors for recurrence of diabetic ketoacidosis and determine interventions to prevent future admissions. Review article. Recurrent diabetic ketoacidosis is a serious and not uncommon health problem. Diabetic ketoacidosis is associated with severe morbidity and mortality and hospital admissions due to this problem constitute a serious economic burden on the healthcare system. Younger age at diabetic ketoacidosis onset, poor baseline glycemic control and elevated HbA1C, patient comorbidities, depression, alcohol or substance abuse, particularly active cocaine use, have been associated with recurrent diabetic ketoacidosis. In addition, socioeconomic factors (such as ethnic minority status, use of public health insurance and underinsurance), psychosocial, economic, and behavioral factors (including financial constraint, stretching a limited insulin supply, and homelessness) have been all reported to be associated with readmission among diabetic ketoacidosis patients. Identifying high-risk patients during the first diabetic ketoacidosis admission and performing relevant interventions (repeated instructions of insulin use, social help and involvement of family members in medical treatment, collaboration with the patient's primary care physician in order to establish a close and frequent follow up program) may help prevent future admissions. Further studies need to take place to determine whether early interventions with those factors prevent future admissions.

Identifiants

pubmed: 31365631
pii: S2359-39972019005006109
doi: 10.20945/2359-3997000000158
pmc: PMC10522260
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

531-535

Références

Diabetes Care. 1993 Aug;16(8):1167-78
pubmed: 8375247
Diabetes Care. 2011 Sep;34(9):1992-7
pubmed: 21788623
Metabolism. 2007 Feb;56(2):172-8
pubmed: 17224329
J Investig Med High Impact Case Rep. 2017 May 24;5(2):2324709617710040
pubmed: 28589154
East Afr Med J. 2005 Dec;82(12 Suppl):S197-203
pubmed: 16619733
J Formos Med Assoc. 2010 Oct;109(10):725-34
pubmed: 20970069
Diabetes Care. 2000 Oct;23(10):1556-62
pubmed: 11023152
J Diabetes Investig. 2016 Mar;7(2):135-8
pubmed: 27042263
Chang Gung Med J. 2005 Jan;28(1):24-30
pubmed: 15804145
Diabetes Care. 2011 Sep;34(9):1891-6
pubmed: 21775761
Ann Intern Med. 2013 Aug 20;159(4):262-74
pubmed: 24026259
Isr Med Assoc J. 2012 May;14(5):299-303
pubmed: 22799061
BMJ. 2000 Jun 10;320(7249):1563-6
pubmed: 10845962
Am J Manag Care. 2010 Oct;16(10):760-7
pubmed: 20964472
Curr Diab Rep. 2013 Feb;13(1):130-7
pubmed: 23115048
Endocr Pract. 2013 Sep-Oct;19(5):829-33
pubmed: 23757621
Acta Diabetol. 2013 Apr;50(2):183-7
pubmed: 21136122
Endocr Pract. 2007 Jan-Feb;13(1):22-9
pubmed: 17360297
Horm Res. 2002;57 Suppl 1:78-80
pubmed: 11979030
J Clin Med Res. 2017 Jan;9(1):35-39
pubmed: 27924173
BMJ. 2006 May 27;332(7552):1259-60
pubmed: 16735337
J Diabetes Investig. 2014 May 4;5(3):265-75
pubmed: 24843771
Diabetes Obes Metab. 2014 Oct;16(10):984-93
pubmed: 24766495
Diabet Med. 2016 Apr;33(4):523-8
pubmed: 26489986
Diabetes Care. 2006 Dec;29(12):2739-48
pubmed: 17130218

Auteurs

Evgenia Brandstaetter (E)

Department of Internal Medicine F, Soroka University Medical Center, Beer-Sheva, Israel.

Carmi Bartal (C)

Department of Internal Medicine E, Soroka University Medical Center, Beer-Sheva, Israel.

Iftach Sagy (I)

Department of Internal Medicine F, Soroka University Medical Center, Beer-Sheva, Israel.
Clinical Research Center, Soroka University Medical Center, Beer Sheva, Israel.

Alan Jotkowitz (A)

Department of Internal Medicine F, Soroka University Medical Center, Beer-Sheva, Israel.

Leonid Barski (L)

Department of Internal Medicine F, Soroka University Medical Center, Beer-Sheva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH